Adagene Inc (ADAG)
2.53
-0.04
(-1.56%)
USD |
NASDAQ |
May 17, 16:00
2.53
0.00 (0.00%)
After-Hours: 20:00
Adagene Total Assets (Quarterly): 115.73M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 115.73M |
June 30, 2023 | 135.30M |
December 31, 2022 | 152.40M |
June 30, 2022 | 178.56M |
December 31, 2021 | 189.51M |
Date | Value |
---|---|
June 30, 2021 | 217.86M |
December 31, 2020 | 84.26M |
September 30, 2020 | 89.08M |
December 31, 2019 | 105.89M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
84.26M
Minimum
Dec 2020
217.86M
Maximum
Jun 2021
140.95M
Average
135.30M
Median
Jun 2023
Total Assets (Quarterly) Benchmarks
Sinovac Biotech Ltd | 13.66B |
CASI Pharmaceuticals Inc | 75.27M |
Zai Lab Ltd | 988.44M |
Gracell Biotechnologies Inc (DELISTED) | 259.03M |
YS Biopharma Co Ltd | 220.84M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 45.17M |
Shareholders Equity (Quarterly) | 70.56M |
Debt to Equity Ratio | 0.3109 |
Current Ratio | 3.606 |
Net Debt Paydown Yield | -2.10% |